Literature DB >> 1968588

Oral iron chelation with L1.

M B Agarwal, C Viswanathan, J Ramanathan, D E Massil, S Shah, S S Gupte, D Vasandani, R R Puniyani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1968588     DOI： 10.1016/0140-6736(90)90380-n

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Oral iron chelation is here.

Authors:  G J Kontoghiorghes
Journal:  BMJ       Date:  1991-11-23

2.  Transport of iron chelators and chelates across MDCK cell monolayers: implications for iron excretion during chelation therapy.

Authors:  Xi-Ping Huang; Jake J Thiessen; Michael Spino; Douglas M Templeton
Journal:  Int J Hematol       Date:  2010-03-09       Impact factor: 2.490

Review 3.  World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients.

Authors:  Christina N Kontoghiorghe; Nicholas Andreou; Katerina Constantinou; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2014-09-26

4.  Transport kinetics of iron chelators and their chelates in Caco-2 cells.

Authors:  Xi-Ping Huang; M Spino; J J Thiessen
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

Review 5.  Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.

Authors:  Annita Kolnagou; Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2014-12-26

Review 6.  Present status and future prospects of oral iron chelation therapy in thalassaemia and other diseases.

Authors:  G J Kontoghiorghes
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

Review 7.  Oral iron chelation: a review with special emphasis on Indian work on deferiprone (L1).

Authors:  M B Agarwal
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.